Highly qualified and technically skilled laboratory leader with extensive experience in establishment and operation of clinical laboratories. Demonstrated excellence in communication and team building/management. Broad experience in quantitative and qualitative assay development. Experience in both academic and industrial laboratory settings and enjoy collaborating with wide variety of scientists (clinicians, informaticians, QC/QA) and business partners (internal and external). Demonstrated ability to prepare regulatory filings, lead regulatory inspections with favorable reports, and maintain certifications once obtained. Responsible for multimillion-dollar laboratory budgets and building teams of laboratory technologists and scientists. Broad knowledge of analytical chemistry, protein chemistry, mass spectrometry, chromatography, spectroscopy, biomarker research and development, assay validation, molecular diagnostics, and cancer research.I have studied and applied a wide variety of mass spectrometry approaches over the past twenty years. Since 2011 I have been working at Indi as Laboratory Director/Senior Director of Laboratory Operations as a key member of the team responsible for discovery and validation of the first protein-targeted MRM MS assay to reach the clinic, Xpresys™ Lung. The assay aims to help physicians identify benign pulmonary nodules with high probability, in an effort to help eliminate unnecessary invasive procedures associated with the diagnosis of pulmonary nodules.Earlier in my career I was part of the Biodesix team that commercialized a MALDI MS assay, now known as Veristrat. I was primarily responsible for establishing a clinical-grade assay in a CLIA-certified mass spectrometry laboratory. Prior to that I was part of an international collaboration that published the discovery and validation of the Veristrat assay, which measured serum proteins to classify non-small-cell lung cancer patients into two groups based on clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors. After receiving my Ph.D. in Analytical Chemistry from Virginia Tech, I joined the staff at the University of Colorado Denver (UCD) School of Medicine, ultimately serving as Assistant Professor. While at UCD, I enjoyed collaborating widely with clinicians and researchers to focus my knowledge of mass spectrometry on the study of proteins and their role in health and disease.